Log in

Relevant bibliographies by topics / Peptide binding

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Peptide binding'

Author: Grafiati

Published: 4 June 2021

Last updated: 6 September 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Peptide binding.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Peptide binding"

1

New, Roger R. C., Tam T. T. Bui, and Michal Bogus. "Binding Interactions of Peptide Aptamers." Molecules 25, no. 24 (2020): 6055. http://dx.doi.org/10.3390/molecules25246055.

Full text

Abstract:

Peptide aptamers are short amino acid chains that are capable of binding specifically to ligands in the same way as their much larger counterparts, antibodies. Ligands of therapeutic interest that can be targeted are other peptide chains or loops located on the surface of protein receptors (e.g., GCPR), which take part in cell-to-cell communications either directly or via the intermediary of hormones or signalling molecules. To confer on aptamers the same sort of conformational rigidity that characterises an antibody binding site, aptamers are often constructed in the form of cyclic peptides,

APA, Harvard, Vancouver, ISO, and other styles

2

Smith, K. D., B. E. Mace, A. Valenzuela, et al. "Probing HLA-B7 conformational shifts induced by peptide-binding groove mutations and bound peptide with anti-HLA monoclonal antibodies." Journal of Immunology 157, no. 6 (1996): 2470–78. http://dx.doi.org/10.4049/jimmunol.157.6.2470.

Full text

Abstract:

Abstract To determine the influence of peptide-binding groove residues and MHC-bound peptide on HLA-B7 conformation, we investigated the binding sites of nine locus- or allele-specific mAbs using a panel of 82 HLA-B7 variants. The functional mAb epitopes encircle the HLA-B7 peptide-binding groove. Three mAbs are affected by mutations at solvent-accessible peptide-binding groove mutations. Mutations in peptide-binding groove residues 45, 63, and 150 affect multiple nonoverlapping mAb epitopes, probably by interaction with other MHC residues or bound peptide. However, 18 of 24 peptide-binding gr

APA, Harvard, Vancouver, ISO, and other styles

3

Nguyen, Andrea T., Christopher Szeto, and Stephanie Gras. "The pockets guide to HLA class I molecules." Biochemical Society Transactions 49, no. 5 (2021): 2319–31. http://dx.doi.org/10.1042/bst20210410.

Full text

Abstract:

Human leukocyte antigens (HLA) are cell-surface proteins that present peptides to T cells. These peptides are bound within the peptide binding cleft of HLA, and together as a complex, are recognised by T cells using their specialised T cell receptors. Within the cleft, the peptide residue side chains bind into distinct pockets. These pockets ultimately determine the specificity of peptide binding. As HLAs are the most polymorphic molecules in humans, amino acid variants in each binding pocket influences the peptide repertoire that can be presented on the cell surface. Here, we review each of t

APA, Harvard, Vancouver, ISO, and other styles

4

Nijenhuis, M., S. Schmitt, E. A. Armandola, R. Obst, J. Brunner, and G. J. Hämmerling. "Identification of a contact region for peptide on the TAP1 chain of the transporter associated with antigen processing." Journal of Immunology 156, no. 6 (1996): 2186–95. http://dx.doi.org/10.4049/jimmunol.156.6.2186.

Full text

Abstract:

Abstract The transporter associated with Ag processing (TAP) translocates cytosolic peptides into the endoplasmic reticulum for presentation by MHC class 1 molecules. Recently, the actual peptide translocation step has been suggested to be preceded by binding of the peptide to TAP. In this study, we investigated the peptide binding site of TAP and its relevance for peptide selection by cross-linking of translocatable peptides. Our data demonstrate, first, that for a TAP heterodimer containing the rat TAPu allelic product, which selects peptides on basis of their C terminus, the translocation e

APA, Harvard, Vancouver, ISO, and other styles

5

Wang, P., G. Gyllner, and S. Kvist. "Selection and binding of peptides to human transporters associated with antigen processing and rat cim-a and -b." Journal of Immunology 157, no. 1 (1996): 213–20. http://dx.doi.org/10.4049/jimmunol.157.1.213.

Full text

Abstract:

Abstract Cytotoxic T lymphocytes recognize antigenic peptides presented by MHC class I molecules. The peptides are generated in the cytosol by proteasomes, and probably also other proteases, and are then translocated into the endoplasmic reticulum (ER) lumen. The transporters associated with Ag processing (TAP) are key molecules for transporting peptides from the cytosol to the lumen of the ER. Using semipermeabilized cells, TAP-dependent peptide translocation was demonstrated, and the selectivity of peptide translocation was based on the carboxyl-terminal amino acid of peptides. We have exami

APA, Harvard, Vancouver, ISO, and other styles

6

Tussey, L. G., M. Matsui, S. Rowland-Jones, R. Warburton, J. A. Frelinger, and A. McMichael. "Analysis of mutant HLA-A2 molecules. Differential effects on peptide binding and CTL recognition." Journal of Immunology 152, no. 3 (1994): 1213–21. http://dx.doi.org/10.4049/jimmunol.152.3.1213.

Full text

Abstract:

Abstract Previous studies have identified several residues lining the groove of the HLA-A2.1 molecule that are critical for Ag presentation. However, it is not clear whether these residues are critical for binding of the peptide epitope per se or for determining the appropriate conformation of bound peptide. To distinguish between these possibilities, mutations at eight of these residues have been tested for their effects on the ability of the molecule to bind and present two known peptide epitopes--one derived from the influenza A matrix protein, the other from HIV pol. With only one exceptio

APA, Harvard, Vancouver, ISO, and other styles

7

McNicholl, J. M., W. C. Whitworth, F. Oftung, et al. "Structural requirements of peptide and MHC for DR(alpha, beta 1*0401)-restricted T cell antigen recognition." Journal of Immunology 155, no. 4 (1995): 1951–63. http://dx.doi.org/10.4049/jimmunol.155.4.1951.

Full text

Abstract:

Abstract We identified functionally important regions of the DR(alpha, beta 1*0401) peptide binding site and present a model of bound peptide. DR(alpha, beta 1*0401)-restricted T cell recognition and peptide binding of Mycobacterium leprae (ML) peptide 38-50 and overlapping peptides from the 18-kDa heat-shock protein were analyzed. ML38-50 is unusual in its restricted binding pattern, binding to only one of five DR4 subtypes and no other DR molecules tested. Amino acid substitutions were introduced into ML38-50 and the DR(alpha, beta 1*0401) peptide binding site at positions likely to influenc

APA, Harvard, Vancouver, ISO, and other styles

8

Choppin, J., F. Martinon, E. Gomard, et al. "Analysis of physical interactions between peptides and HLA molecules and application to the detection of human immunodeficiency virus 1 antigenic peptides." Journal of Experimental Medicine 172, no. 3 (1990): 889–99. http://dx.doi.org/10.1084/jem.172.3.889.

Full text

Abstract:

The physical association of 40 antigenic peptides and purified HLA class I and class II molecules was monitored using a direct peptide binding assay (PBA) in solid phase and an inhibition peptide binding assay (IPBA) in which the competing peptide was present in a soluble phase. We also examined the ability of different peptides to inhibit the lytic activity of human antiviral cytolytic T cells towards cells incubated with the corresponding target peptide. Our results showed that: (a) Binding of a given human T cell-recognized peptide to several HLA class I and class II molecules occurred freq

APA, Harvard, Vancouver, ISO, and other styles

9

Kaveri, S. V., C. Y. Kang, and H. Köhler. "Natural mouse and human antibodies bind to a peptide derived from a germline VH chain. Evidence for evolutionary conserved self-binding locus." Journal of Immunology 145, no. 12 (1990): 4207–13. http://dx.doi.org/10.4049/jimmunol.145.12.4207.

Full text

Abstract:

Abstract Murine antibodies derived from the V1 S107/T15 germline structure combined with Vk 22 L chains express the property of self-binding. Previous studies have shown that the self-binding is mediated by the Fab fragment involving structures of the hapten binding site. The molecular locus of self-binding has also been identified by showing that a peptide derived from the CDR2/FR3 region of the V1 S107 H chain inhibits self-binding. We have addressed the question of whether self-binding antibodies interact with peptides that inhibit self-binding. We found that labeled TEPC15 (T15) binds to i

APA, Harvard, Vancouver, ISO, and other styles

10

Ojcius, D. M., J. P. Abastado, A. Casrouge, E. Mottez, L. Cabanie, and P. Kourilsky. "Dissociation of the peptide-MHC class I complex limits the binding rate of exogenous peptide." Journal of Immunology 151, no. 11 (1993): 6020–26. http://dx.doi.org/10.4049/jimmunol.151.11.6020.

Full text

Abstract:

Abstract Soluble, single-chain molecules for two MHC class I alleles, H-2Kd and H-2Kb, were used to analyze the kinetics of antigenic peptide binding to MHC. After MHC preloading with radiolabeled or fluorescent peptides, the observed rate of MHC-peptide complex dissociation increased after addition of an excess of unlabeled competitor peptide. Although exogenous peptides conforming to the allele-specific motif were required for the enhanced complex dissociation to occur, the dissociation rate of the complex was independent of exogenous peptide concentration. Similarly, the association rate of

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Peptide binding"

1

Zhang, Zhiwen. "Towards peptide-binding peptides." Access restricted to users with UT Austin EID, 2001. http://wwwlib.umi.com/cr/utexas/fullcit?p3037037.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Onkar, Sayali S. "Cholesterol Binding Activity of ApoAI Mimetic Peptide L4F." University of Toledo Health Science Campus / OhioLINK, 2013. http://rave.ohiolink.edu/etdc/view?acc_num=mco1363726316.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Barouch, Dan H. "Peptide binding and presentation by HLA-A2." Thesis, University of Oxford, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.294263.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Dunn, James Albert. "Single Molecule Characterization of Peptide/Hematite Binding." The Ohio State University, 2017. http://rave.ohiolink.edu/etdc/view?acc_num=osu1494014864020062.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Widenbring, Ronja. "Microgel Interactions with Peptides and Proteins : Consequence of Peptide and Microgel Properties." Doctoral thesis, Uppsala universitet, Institutionen för farmaci, 2015. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-242893.

Full text

Abstract:

Microgels are lightly cross-linked hydrogel particles in the sub-micrometer to micrometer size range with a capacity to drastically change their volume in response to changes in the external environment. Microgels have an ability to bind and store substances such as biomacromolecular drugs, notably proteins and peptides, and release them upon stimuli, making them potential candidates as drug delivery vehicles and functional biomaterials. This thesis aims at clarifying important factors affecting peptide-microgel interactions. These interactions were studied by micromanipulator-assisted light a

APA, Harvard, Vancouver, ISO, and other styles

6

Umurtak, H. B. "Studies on DNA-binding peptides]." Thesis, University of Southampton, 1989. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.235192.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Mansouri, Ahmad. "Computational modeling of osteopontin peptide binding to hydroxyapatite." Thesis, McGill University, 2011. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=104546.

Full text

Abstract:

Osteopontin (OPN), a secreted, noncollagenous, acidic, and mineral-binding phosphoprotein, is composed of 314 amino acids (in humans), mostly composed of glutamate, aspartate and serine. It is prominently associated with biominerals and has a regulatory effect on hydroxyapatite (HAP) crystal growth, the mineral phase of bones and teeth. Recent studies have revealed that OPN contains an acidic, serine- and aspartate-rich motif (ASARM), which potently inhibits mineralization of osteoblast cultures in a phosphate-dependent manner. ASARM peptides accumulate in hypophosphatemia patients whose disti

APA, Harvard, Vancouver, ISO, and other styles

8

Wareham, Richard Stuart. "Studies towards bicyclic macrocycles with peptide binding potential." Thesis, University of Southampton, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.261113.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Schouten, James Alexander. "Probing selective G-quadruplex binding using peptide motifs." Thesis, University of Cambridge, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.620018.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Tran, Phuong My. "Anthrapyrazole cysteinyl peptides as inhibitors of AP-1 transcription factor binding." Thesis, De Montfort University, 1998. http://hdl.handle.net/2086/10703.

Full text

Abstract:

Synthesis of peptides anchored to DNA by intercalating chromophores can incorporate the design principle of the naturally occurring peptide based antibiotics. This work is concerned with the synthesis of DNA anchored cysteinyl peptides designed to be potentially nucleotide sequence specific with possible affinity for the AP-l transcription site. Previous work has shown that anthraquinones and anthrapyrazoles (APZs) substituted with cationic side groups are excellent DNA intercalating agents. In this work a series of APZ analogues has been synthesised which are coupled onto the amino terminus o

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Peptide binding"

1

Shmuel, Cabilly, ed. Combinatorial peptide library protocols. Humana Press, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Ijaz, Taeeba. Anthraquinone-peptide conjugates as inhibitors of DNA transcription factor binding. De Montfort University, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Keane, Anita M. Peptide mimetics of an actin-binding site on the myosin head. University of Birmingham, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Miguel A. R. B. Castanho. Membrane-active peptides: Methods and results on structure and function. International University Line, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Christinck, E. Rosemary. Properties of the peptide-MHC Class I molecule binding interaction on living cells. National Library of Canada = Bibliothèque nationale du Canada, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Membrane-active peptides: Methods and results on structure and function. International University Line, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

M, Bergfors Terese, ed. Protein crystallization. International University Line, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Phuong, My Tran. "Anthrapyrazole cysteinyl peptides as inhibitors of AP-1 transcription factor binding". De Montfort University, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Schmidt, Holger. NMR-Lösungsstruktur der humanen Hck SH3-Domäne im Komplex mit einem artifiziellen, hochoffinen Peptid-Liganden. Forschungszentrum Jülich, Zentralbibliothek, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Proteins: Membrane binding and pore formation. Springer Science+Business Media, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Peptide binding"

1

Sawada, Toshiki, and Takeshi Serizawa. "Identification and Application of Polymer-Binding Peptides." In Peptide Materials. John Wiley & Sons, 2013. http://dx.doi.org/10.1002/9781118592403.ch15.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Houston, Michael, Heman Chao, Michèle C. Loewen, et al. "A new paradigm for fish antifreeze protein binding to ice." In Peptides Frontiers of Peptide Science. Springer Netherlands, 2002. http://dx.doi.org/10.1007/0-306-46862-x_326.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Care, Andrew, Peter L. Bergquist, and Anwar Sunna. "Solid-Binding Peptides in Biomedicine." In Peptides and Peptide-based Biomaterials and their Biomedical Applications. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-66095-0_2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Yanover, Chen, and Tomer Hertz. "Predicting Protein-Peptide Binding Affinity by Learning Peptide-Peptide Distance Functions." In Lecture Notes in Computer Science. Springer Berlin Heidelberg, 2005. http://dx.doi.org/10.1007/11415770_34.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

de Haan, Ellen C., Marca H. M. Wauben, Mayken C. Grosfeld-Stulemeyer, John A. W. Kruijtzer, Rob M. J. Liskamp, and Ed E. Moret. "Peptoid-Peptide Hybrids: Design, Synthesis and MHC Binding." In Peptides: The Wave of the Future. Springer Netherlands, 2001. http://dx.doi.org/10.1007/978-94-010-0464-0_489.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Kaur, Kamaljit, Sahar Ahmed, Rania Soudy, and Sarfuddin Azmi. "Screening Peptide Array Library for the Identification of Cancer Cell-Binding Peptides." In Peptide Libraries. Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-2020-4_16.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Chen, Gang, Zhixiang Zuo, Qi Zhu, et al. "Qualitative and Quantitative Analysis of Peptide Microarray Binding Experiments Using SVM-PEPARRAY." In Peptide Microarrays. Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60327-394-7_23.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Briant, Douglas J., James M. Murphy, Genie C. Leung, and Frank Sicheri. "Rapid Identification of Linear Protein Domain Binding Motifs Using Peptide SPOT Arrays." In Peptide Microarrays. Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60327-394-7_6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Mukai, Hidehito, Eisuke Munekata, and Tsutomu Higashijima. "Antagonists of GTP-binding regulatory proteins (G proteins): Substance P-related peptides compete with a receptor for G protein binding." In Peptide Chemistry 1992. Springer Netherlands, 1993. http://dx.doi.org/10.1007/978-94-011-1474-5_94.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Fesik, Stephen, Andrew Petros, Timothy Logan, et al. "Multidimensional NMR studies of immunosuppressants and their binding proteins." In Peptide Chemistry 1992. Springer Netherlands, 1993. http://dx.doi.org/10.1007/978-94-011-1474-5_63.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Peptide binding"

1

D’Souza, S. E., M. H. Ginaberg, S. Lam, and E. A. Plow. "ACTIVATION DEPENDENT ALTERATIONS IN THE CHEMICAL CROSSLINKING OF ARGINYL-GLYCYL-ASPARTIC ACID (RGD) PEPTIDES WITH PLATELET GLYCOPROTEIN (GP) GPIIb-IIIa." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643699.

Full text

Abstract:

The platelet adhesive proteins, fibrinogen, fibronectin and von WillebrandFactor, contain RGD amino acid sequences; RGD-containing peptides inhibit the binding of these adhesive proteins to platelets; and a membrane receptor for these adhesive proteins binds to Arg-Gly-Asp and contains GPIIb-IIIa. The present study was undertaken to characterize the interaction of RGDpeptides with GPIIb-IIIa using a chemical crosslinking approach. A radioiodinated RGD-containing heptapeptide was bound to washed human platelets under conditions at which ≥ 85% of theinteraction was inhibited by excess nonlabeled

APA, Harvard, Vancouver, ISO, and other styles

2

Niu, Yanqing. "Predicting Class-II MHC Binding Peptide Using Global Representation of Peptides." In 2011 International Conference on Intelligent Computation and Bio-Medical Instrumentation (ICBMI). IEEE, 2011. http://dx.doi.org/10.1109/icbmi.2011.74.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Lam, S., E. F. Plow, A. L. Frelinger III, M. A. Smith, J. C. Loftus, and M. H. Ginsberg. "ARG-GLY-ASP (RGD) PEPTIDES INCREASE THE EXPOSURE OF THE CARBOXYL TERMINAL REGION OF THE HEAVY CHAIN OF GPIIB ON THE PLATELET SURFACE." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643698.

Full text

Abstract:

RGD peptides and those derived from the fibrinogen γ chain (e.g., γ 400-411 (H12)) are inhibitors of platelet aggregation and fibrinogen binding. These two sets of peptides interact with a common adhesive protein receptor on platelets which contains GPIIb-IIIa (JBC, 262:947, 1987). A 17 amino acid sequence near the carboxyl terminus of GPIIbα recognized by the PMI-1 monoclonal antibody (JCI, 78:1103, 1986), isexpressed on the cell surface under certain conditions which are not permissive for fibrinogen binding. Thus, achange in the surface orientation of GPIIb is associated with inhibitionofpl

APA, Harvard, Vancouver, ISO, and other styles

4

Iwamoto, M., N. Sugiyama, T. Sasaki та Y. Abiko. "DOMAIN OF BINDING ACTIVITY WITH PLASMIN KRINGLE IN SYNTHESIZED C-TERMINAL PEPTIDES , OF α2-PLASMIN INHIBITOR". У XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644612.

Full text

Abstract:

The inhibitory reaction between plasmin and α2-plasmin inhibitor (α2-PI) proceeds with two steps, a very fast reversible reaction followed by a slower irreversible transition. The first step is dependent on the interaction between lysine binding site (LBS) of plasmin and the corresponding complementary site of α2-PI (kringle binding site(KBS)). It has been reported that KBS is located in a C-terminal tryptic fragment (T-11; J. Biochem. 99, 1699 (1986)).In order to investigate which amino acid residues of T-ll play important roles in binding of plasmin kringle, we tested inhibitory activity of

APA, Harvard, Vancouver, ISO, and other styles

5

Stüber, W., H. Pelzer, and N. Heimburger. "INDUCTION OF ANTITHROMBIN III (AT III) ANTIBODIES BY IMMUNIZATION WITH SYNTHETIC PEPTIDES." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644355.

Full text

Abstract:

The primary structure of AT III was examined in respect of potential antigenic sites. The topics were the determination of the hydrophilicity, hydropathy, acrophilicity and the propensities for alpha-helices, B-turns and 13-sheets. The peptides AT III 21-34, 21-42, 129 - 140, 226 - 240 and 343 -363 were synthesized using the solid phase peptide synthesis methode. The subsequent purification of the crude peptides was achieved by h.p.I.e. or by ion exchange chromatography. The peptides were coupled to keyhole limpet hemocyanine (KLH) via thioether bonds. Antisera against KLH-peptides were raised

APA, Harvard, Vancouver, ISO, and other styles

6

Ferracane, Michael J., and Jane V. Aldrich. "Opioid Ligand Binding to Opioid Receptors: Insight and Implications for Peptide Design." In The 24th American Peptide Symposium. Prompt Scientific Publishing, 2015. http://dx.doi.org/10.17952/24aps.2015.022.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Bacon-Baguley, Theresa, Suzanne Kendra-Franczak та Daniel Walz. "THROMBOSPONDIN SPECIFICALLY INTERACTS WITH AMINO ACID SEQUENCES WITHIN THE A α- AND B β- CHAINS OF FIBRINOGEN". У XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643822.

Full text

Abstract:

Thrombospondin (TSP) is responsible for the secretion-dependent phase of platelet aggregation. The mechanism of this action is believed to be through the binding of TSP to fibrinogen, resulting in the stabilization of the platelet aggregate. It has been established that the binding of fibrinogen to the platelet surface is dependent upon peptide sequences present, respectively, in the Aa- and y-chains. We have hypothesized that the binding of TSP to fibrinogen is also dependent upon unique fibrinogen peptide sequences. To test this hypothesis we have examined the interaction of TSP and f.ih.r.i

APA, Harvard, Vancouver, ISO, and other styles

8

LOFTUS, J. C., E. F. Plow, A. L. Frelinger III, M. A. Smith, S. D’ouza, and M. H. Ginsberg. "LOCALIZATION AND CHEMICAL SYNTHESIS OF A DIVALENT CATION REGULATED EPITOPE IN PLATELET MEMBRANE GPIIb." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643959.

Full text

Abstract:

Platelet membrane glycoprotein (GP)IIb-IIIa is a component of a common adhesive protein receptor for fibrinogen, fibronectin, and von Willebrand factor. A monoclonal antibody, PMI-1, defines a divalent cation dependent regulation of the surface orientation of the heavy chain of GPIIb. Exposure of the PMI-1 epitope inversely correlates with the capacity of platelets to bind fibrinogen and aggregate. We have now localized and chemically synthesized this epitope. A 1.1 Kb cDNA clone which directs the synthesis of a fusion protein which bears the PMI-1 epitope was isolated from a lambda gt 11 expr

APA, Harvard, Vancouver, ISO, and other styles

9

Fraczak, Oliwia, Anika Lasota, Adriana Muchowska та ін. "Dimeric Dermorphin Analogues Containing β3-Homo-Amino Acids: Synthesis, Binding Affinities and Metabolic Stability". У The 24th American Peptide Symposium. Prompt Scientific Publishing, 2015. http://dx.doi.org/10.17952/24aps.2015.077.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Fernández-Llamazares, Ana I., Kevin C. M. Hermans, Peter Timmerman, and W. Matthijs Blankesteijn. "Mimicking the Binding Sites of Wnt Proteins: Rational Design of Wnt/Fzd-Signaling Modulators." In The 24th American Peptide Symposium. Prompt Scientific Publishing, 2015. http://dx.doi.org/10.17952/24aps.2015.212.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Peptide binding"

1

Underhill, Charles B., and Lurong Zhang. Therapeutic Effect of Targeted Hyaluronan Binding Peptide on Neurofibromatosis. Defense Technical Information Center, 2004. http://dx.doi.org/10.21236/ada431642.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Zhang, Lurong. Therapeutic Effect of Targeted Hyaluronan Binding Peptide on Neurofibromatosis. Defense Technical Information Center, 2002. http://dx.doi.org/10.21236/ada412140.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Underhill, Charles B., and Lurong Zhang. Therapeutic Effect on Targeted Hyaluronan Binding Peptide on Neurofibromatosis. Defense Technical Information Center, 2005. http://dx.doi.org/10.21236/ada507414.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Zhang, Lurong. Therapeutic Effect of Targeted Hyaluronan Binding Peptide on Neurofibromatosis. Defense Technical Information Center, 2003. http://dx.doi.org/10.21236/ada420850.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Vouros, Paul, and Terrance Black. Solid Phase Peptide Synthesis of Antimicrobial Peptides for cell Binding Studies: Characterization Using Mass Spectrometry. Defense Technical Information Center, 2002. http://dx.doi.org/10.21236/ada412571.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

DeFreest, Lori A., and James A. Bennett. Identification of Cellular Binding Sites for a Novel Human Anti-Breast Cancer Peptide. Defense Technical Information Center, 2003. http://dx.doi.org/10.21236/ada416487.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

DeFreest, Lori, and James Bennett. Identification of Cellular Binding Sites for a Novel Human Anti-Breast Cancer Peptide. Defense Technical Information Center, 2004. http://dx.doi.org/10.21236/ada425751.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Subjeck, John. Use of the HSP 110 Peptide Binding Protein for the Development of New Breast Cancer Vaccines. Defense Technical Information Center, 2000. http://dx.doi.org/10.21236/ada393271.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Gurevitz, Michael, William A. Catterall, and Dalia Gordon. face of interaction of anti-insect selective toxins with receptor site-3 on voltage-gated sodium channels as a platform for design of novel selective insecticides. United States Department of Agriculture, 2013. http://dx.doi.org/10.32747/2013.7699857.bard.

Full text

Abstract:

Voltage-gated sodium channels (Navs) play a pivotal role in excitability and are a prime target of insecticides like pyrethroids. Yet, these insecticides are non-specific due to conservation of Navs in animals, raising risks to the environment and humans. Moreover, insecticide overuse leads to resistance buildup among insect pests, which increases misuse and risks. This sad reality demands novel, more selective, insect killers whose alternative use would avoid or reduce this pressure. As highly selective insect toxins exist in venomous animals, why not exploit this gift of nature and harness t

APA, Harvard, Vancouver, ISO, and other styles

10

Baszler, Timothy, Igor Savitsky, Christopher Davies, Lauren Staska, and Varda Shkap. Identification of bovine Neospora caninum cytotoxic T-lymphocyte epitopes for development of peptide-based vaccine. United States Department of Agriculture, 2006. http://dx.doi.org/10.32747/2006.7695592.bard.

Full text

Abstract:

The goal of the one-year feasibility study was to identify specific cytotoxic T-lymphocyte (CTL) epitopes to Neosporacaninum in the natural bovine host in order to make progress toward developing an effective peptide-based vaccine against bovine neosporosis. We tested the hypothesis that: N. caninum SRS2 peptides contain immunogenicCTLepitope clusters cross-presented by multiple bovine MHC-I and MHC-IIhaplotypes. The specific objectives were: (1) Map bovine CTLepitopes of N. caninum NcSRS-2 and identify consensus MHC-I and class-II binding motifs; and (2) Determine if subunit immunization with

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!